Home › Funds › Tetragon Partners GP Ltd › AMLX

Tetragon Partners GP Ltd position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

Tetragon Partners GP Ltd reported holding 8,500 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$153K, representing 0.02% of its reported portfolio and ranking #36 among its reported holdings. Tetragon Partners GP Ltd has disclosed AMLX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)8.50K sh
Reported value held$152.66K
Portfolio Weight0.02%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's AMLX position evolved

Tetragon Partners GP Ltd first disclosed a stake in AMLX in Q2 2025 at 218,750 shares (US$1.4M). The position peaked in Q1 2026 at 317,877 shares, worth US$4.4M. Across 5 filings, Tetragon Partners GP Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 8,500 shares valued at US$153K — a reduction of -309,377 shares quarter over quarter.. Notable position changes include a 97% trim in Q2 2026 (shares rose 62% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 218.75K $1.40M New
Q3 2025 258.24K $3.51M Add
Q4 2025 272.83K $3.30M Add
Q1 2026 317.88K $4.42M Add
Q2 2026 8.50K $152.66K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has Tetragon Partners GP Ltd held AMLX?

Tetragon Partners GP Ltd has disclosed AMLX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Tetragon Partners GP Ltd's current position in AMLX?

As of Q2 2026, Tetragon Partners GP Ltd holds 8.50K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $152.66K, representing 0.02% of its reported portfolio and ranking #36.

Has Tetragon Partners GP Ltd been buying or selling AMLX?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd reduced its position in AMLX. The position peaked in Q1 2026 at 317.88K shares.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.